Indivumed Services
Jan Schumacher currently serves as the Director of Quality & Regulatory Affairs at Indivumed Services, a position held since March 2023. Prior to this role, Jan held the title of Director of Quality Management at Indivumed Group from April 2020 to February 2023. Jan's experience also includes working as a Qualitätsmanager (stellvertretender Leiter Qualitätssicherung) and Qualitätsmanager at Eurofins BioPharma Product Testing Hamburg GmbH from October 2017 to March 2020. Earlier in Jan's career, roles included Wissenschaftlicher Mitarbeiter (Teamleiter Bereich Chromatographie) and Wissenschaftlicher Mitarbeiter at Miltenyi Biotec from January 2016 to October 2017. Jan Schumacher holds a Diplom in Chemistry from Kiel University.
This person is not in any teams
Indivumed Services
Indivumed Services, a Crown Bioscience Company, is a global contract research organization (CRO) that offers an industry-leading oncology biobank and a range of service platforms to advance oncology and immuno-oncology drug discovery and development. Holding a unique biobank of clinical specimens, unrivalled in quality and associated clinical history, which currently totals almost one million patient samples, the company partners with extensive clinical network of more than 60 entities in the United States, Europe, and Asia providing direct and controlled access to relevant surgical biospecimens and blood samples. Further known for their enhanced immunohistochemistry and spatial transcriptomics, Indivumed Services’ platforms complement a range of established Crown Bioscience capabilities supporting biomarker discovery. Imprint: https://www.indivumedservices.com/imprint